The pharmaceutical landscape in the United States is witnessing a transformative phase as industry giants accelerate their expansion within the neurodegenerative treatment sector. With a robust healthcare infrastructure and a high rate of clinical diagnosis, the U.S. Dementia Drugs Market is serving as the primary staging ground for the next generation of disease-modifying therapies. This...